Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Rogers

Showing results (81-90 of 196) with videos related to

Pageof 20
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 17, 2007
Transition from bare metal to drug eluting stenting in contemporary US practice: effect on incidence and predictors of clinically driven target lesion revascularizationMichael Jonas, Frederic S Resnic, Andrew D Levin, et al.
Burns : Journal of the International Society for Burn Injuries|January 29, 2014
Ventilator associated pneumonia in major paediatric burnsAlan David Rogers, Cailin Deal, Andrew Charles Argent, et al.
Antimicrobial Agents and Chemotherapy|June 18, 2014
SAGA/ADA complex subunit Ada2 is required for Cap1- but not Mrr1-mediated upregulation of the Candida albicans multidrug efflux pump MDR1Bernardo Ramírez-Zavala, Selene Mogavero, Eva Schöller, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2014
Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicansStephanie A Flowers, Brendan Colón, Sarah G Whaley, et al.
Proteomics. Clinical Applications|December 8, 2010
Proteomic analysis of Mrr1p- and Tac1p-associated differential protein expression in azole-resistant clinical isolates of Candida albicansChristopher F Hoehamer, Edwin D Cummings, George M Hilliard, et al.
Proteomics|September 15, 2009
Upc2p-associated differential protein expression in Candida albicansChristopher F Hoehamer, Edwin D Cummings, George M Hilliard, et al.
Cold Spring Harbor Perspectives in Medicine|November 12, 2014
Mechanisms of Antifungal Drug ResistanceLeah E Cowen, Dominique Sanglard, Susan J Howard, et al.
Journal of Surgical Education|May 30, 2025
What is the Medical Student Experience of Incivilities on the Surgery Clerkship and Do They Matter?Gazi Rashid, Esther Kim, Amy Evenson, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 4, 2023
Mutations in TAC1 and ERG11 are major drivers of triazole antifungal resistance in clinical isolates of Candida parapsilosisLaura A Doorley, Katherine S Barker, Qing Zhang, et al.
Pharmacotherapy|August 19, 2003
Effects of amphotericin B and caspofungin on histamine expressionJohn D Cleary, Michael Schwartz, P David Rogers, et al.
Pageof 20

Showing results (81-90 of 196) with videos related to

Sort By:
Pageof 20
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 17, 2007
Transition from bare metal to drug eluting stenting in contemporary US practice: effect on incidence and predictors of clinically driven target lesion revascularizationMichael Jonas, Frederic S Resnic, Andrew D Levin, et al.
Burns : Journal of the International Society for Burn Injuries|January 29, 2014
Ventilator associated pneumonia in major paediatric burnsAlan David Rogers, Cailin Deal, Andrew Charles Argent, et al.
Antimicrobial Agents and Chemotherapy|June 18, 2014
SAGA/ADA complex subunit Ada2 is required for Cap1- but not Mrr1-mediated upregulation of the Candida albicans multidrug efflux pump MDR1Bernardo Ramírez-Zavala, Selene Mogavero, Eva Schöller, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2014
Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicansStephanie A Flowers, Brendan Colón, Sarah G Whaley, et al.
Proteomics. Clinical Applications|December 8, 2010
Proteomic analysis of Mrr1p- and Tac1p-associated differential protein expression in azole-resistant clinical isolates of Candida albicansChristopher F Hoehamer, Edwin D Cummings, George M Hilliard, et al.
Proteomics|September 15, 2009
Upc2p-associated differential protein expression in Candida albicansChristopher F Hoehamer, Edwin D Cummings, George M Hilliard, et al.
Cold Spring Harbor Perspectives in Medicine|November 12, 2014
Mechanisms of Antifungal Drug ResistanceLeah E Cowen, Dominique Sanglard, Susan J Howard, et al.
Journal of Surgical Education|May 30, 2025
What is the Medical Student Experience of Incivilities on the Surgery Clerkship and Do They Matter?Gazi Rashid, Esther Kim, Amy Evenson, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 4, 2023
Mutations in TAC1 and ERG11 are major drivers of triazole antifungal resistance in clinical isolates of Candida parapsilosisLaura A Doorley, Katherine S Barker, Qing Zhang, et al.
Pharmacotherapy|August 19, 2003
Effects of amphotericin B and caspofungin on histamine expressionJohn D Cleary, Michael Schwartz, P David Rogers, et al.
Pageof 20